vancomycin has been researched along with Acute Kidney Injury in 379 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (2.64) | 18.7374 |
1990's | 20 (5.28) | 18.2507 |
2000's | 20 (5.28) | 29.6817 |
2010's | 179 (47.23) | 24.3611 |
2020's | 150 (39.58) | 2.80 |
Authors | Studies |
---|---|
Khalili, H; Mohammadi, M; Mostafavi, Z; Rahmani, H; Salehi, M | 1 |
Chen, LP; Guo, Y; Huang, QR; Shi, HH; Wang, CC; Wang, YM; Xue, CH; Zhang, TT | 1 |
Li, T; Liu, K; Mao, H; Ni, J; Wu, B; Xing, C; Xu, X; Zhang, Y | 1 |
Aizawa, F; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izumi, Y; Nakamoto, A; Okada, N; Yagi, K; Zamami, Y | 1 |
Cho, H; Kim, JY; Kwak, S | 1 |
Brateanu, A; Imrey, PB; Le, P; Navaneethan, SD; Pallotta, AM; Patel, P; Rastogi, R; Rothberg, MB; Yu, PC | 1 |
Hebert, S; Tantranont, N; Truong, LD | 1 |
Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS | 1 |
Mendu, DR; Riollano Cruz, M; Tosi, MF | 1 |
Katagiri, H; Mitsuboshi, S | 1 |
Al Harbi, S; Al Sulaiman, K; Alghamdi, N; Alharbi, A; Alhelal, K; Aljuhani, O; Alsaeed, A; Alshaya, A; Alshehri, N; Althewaibi, S; Alzahrani, H; Vishwakarma, R | 1 |
Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
Ganapathi, L; Greco, KF; Hambrick, HR; Lehmann, LE; Sandora, TJ; Weller, E | 1 |
Chen, CH; Chen, YC; Chen, YT; Huang, WC; Lai, TS; Lee, KH; Shao, SC; Su, CH; Sung, JM; Wang, MT | 1 |
Imai, S; Kadomura, S; Kashiwagi, H; Miyai, T; Sato, Y; Sugawara, M; Takekuma, Y | 1 |
Balan, S; Bjork, L; Borick, JJ; Lichtenberger, P | 1 |
Chen, Q; Chen, Y; Huang, Z; Lin, M; Lin, W; Lin, X; Shen, W; Wan, J | 1 |
Chen, YC; Kan, WC; Shiao, CC; Wu, VC | 1 |
Beaubien Souligny, W; Cailhier, JF; Côté, JM; Desjardins, M; Murray, PT | 1 |
Chenqi, X; Kunming, P; Qian Zhou, L; Qing, X; Xiaoqiang, D; Xiaotian, J | 1 |
Bace, E; Bris, R; Kacirova, I; Kanova, M; Klementa, V; Martinek, A; Petejova, N; Pribylova, L; Sigutova, R; Stejskal, D; Svagera, Z; Zadrazil, J | 1 |
Moeckel, GW; Perazella, MA; Rehan, A | 1 |
Harada, S; Matsuoka, S; Mizusaki, Y; Niwa, T; Otsubo, M; Suzuki, A; Yamada, M; Yamada, Y; Yamamoto, T; Yasue, M | 1 |
Gwak, HS; Han, JM; Kim, JY; Yee, J; Yoon, HY | 1 |
Alamoudi, SA; Alharbi, HA; Aljohani, HA; Basurrah, SA; Thabit, AK | 1 |
Chinzowu, T; Chyou, TY; Nishtala, PS | 1 |
Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH | 1 |
Agyekum, RS; Anderson, BJ; Cosgriff, CV; Dunn, TG; Giannini, HM; Hennessy, S; Ittner, CAG; Jones, TK; Meyer, NJ; Miano, TA; Oniyide, O; Reilly, JP; Shashaty, MGS; Townsend, R; Turner, AP; Weisman, AR; Wilson, FP; Yang, W | 1 |
Bhakta, Z; Gray, K; Leclair, L; Lindley, B; Watanabe, A; Young, DC | 1 |
Drennan, P; Eyre, DW; Gu, Q; Jones, N; Peto, TE; Walker, AS | 1 |
Bian, L; He, K; Liang, W; Lv, J; Wu, Z; Yue, H | 1 |
Baczek, SM; Cohen, JA; Hodge, LA; Ingemi, AI; Kaplan, MC; Kiley, PS; Pearston, AP; Shaeffer, ZA; Soriano, KM; Stanley, JS; Talt, IE; Wilson, TJ; Yao, A | 1 |
Abdelmessih, E; Adams, C; Brunetti, L; Crovetto, B; Patel, N; SanFilippo, S; Vekaria, J | 1 |
Benito, J; Corces, A; Higuera, CA; Judd, H; Pannu, TS; Villa, JM | 1 |
Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C | 1 |
Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC | 1 |
Côté, JM; Kane-Gill, SL; Murray, PT | 1 |
Goto, R; Inose, R; Ishikane, M; Koizumi, R; Kusama, Y; Muraki, Y; Ohmagari, N; Ono, A | 1 |
Brinton, JT; Gist, KM; Hebert, M; Holsteen, PE; Iwanowski, M; Kim, A; Leath, A; Marschner, MN; Shah, A; Soranno, DE | 1 |
Asada, M; Azuma, M; Bando, T; Chuma, M; Goda, M; Hamano, H; Ishida, S; Ishizawa, K; Izawa-Ishizawa, Y; Izumi, Y; Kasamo, S; Kondo, M; Miyata, K; Niimura, T; Okada, N; Takechi, K; Tasaki, Y; Yagi, K; Yanagawa, H; Yoshioka, T; Zamami, Y | 1 |
Autry, E; Kormelink, L; Kuhn, R; Mitchell, B; Schadler, A | 1 |
Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
Mullaney, SR | 1 |
Barreto, EF; Murphy, ME | 1 |
Burnett, YJ; George, IA; Hamad, T; Hamad, Y; Nickel, KB; Olsen, MA | 1 |
Oda, K | 1 |
Cai, Q; Cao, Y; Chen, C; Gao, P; Hou, FF; Hu, Y; Johnson, DW; Kong, Y; Li, G; Li, H; Liu, B; Liu, H; Liu, X; Lu, F; Nie, S; Shen, J; Shi, Y; Su, G; Tang, Y; Wan, Q; Weng, J; Xiao, C; Xie, D; Xu, G; Xu, H; Xu, X; Yang, Q; Zha, Y; Zhou, Y | 1 |
Cerenzio, J; Truong, J | 1 |
Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA | 1 |
Chang, J; Engel, PL; Klimek, P; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K | 1 |
Goldstein, SL; Griffin, BR; Hounkponou, H; Jalal, D; Misurac, J; Reisinger, HS; Vaughan-Sarrazin, M; Wendt, L | 1 |
Cabral, SM; Cosgrove, SE; Goodman, KE; Harris, AD; Magder, LS; Tamma, PD | 1 |
Echizenya, M; Harada, S; Okamoto, K; Takada, T; Tsutsumi, T; Yamaguchi, R; Yamamoto, T | 1 |
Armengol de la Hoz, MÁ; Becker, CD; Calvachi-Prieto, P; Celi, LA; Chen, AY; Chen, C; Dagan, A; Deng, CY; Johnson, AEW; Khazi-Syed, A; Scurlock, C | 1 |
Deng, YX; Gu, XR; Li, DK; Liu, K; Qiu, QX; Que, RM; Tang, ZY; Wu, YF; Yin, WJ; Zhou, GL; Zhou, LY; Zuo, XC | 1 |
Amin, R; Chaudhry, YP; Hayes, H; LaGreca, M; Papadelis, E; Rao, SS | 1 |
Sun, XY; Wang, M; Yan, W; Zhao, FF; Zhou, QT | 1 |
Blackburn, BE; Certain, LK; Gililland, JM; Gray, KF; Pelt, CE; Savas, MJ | 1 |
Li, M; Lin, Y; Lv, L; Wu, L; Xie, D; Zhang, Y; Zhao, L | 1 |
Kim, EK; Kim, HS; Park, SG; Shin, BS; Shin, SH | 1 |
Bio, L; Brockmeyer, JM; Frymoyer, A; Schwenk, HT | 1 |
Barreto, EF; Chang, J; Lesnicki, E; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K | 1 |
Hanai, Y; Hasegawa, T; Hirayama, S; Kusano, A; Matsumoto, T; Matsuo, K; Nishizawa, K; Shimoyama, K; Uekusa, S; Yokoo, T | 1 |
Côté, JM; Desjardins, M; Murray, PT | 1 |
Hirai, T; Ishitsuka, Y; Iwamoto, T; Kondo, Y; Sakazaki, Y; Seki, A | 1 |
Hu, M; Wang, Y; Xiang, S; Xu, H; Yang, X; Zhang, Y | 1 |
Ayar, Y; Caliskan, G; Ceylan, İ; Kaya, PK; Kilic, I | 1 |
Ghasemiyeh, P; Mohammadi-Samani, S; Vazin, A; Zand, F | 1 |
Hao, G; Wang, M; Wu, YE; Yin, R; Zhao, W; Zheng, Y; Zhou, Y | 1 |
Kobayashi, R; Niwa, K; Niwa, T; Ono, Y; Otsubo, M; Sumi, K; Suzuki, A; Yamada, S; Yamada, Y; Yamamoto, T; Yasue, M | 1 |
Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF | 1 |
Perazella, MA | 1 |
Batista, ISF; de Almeida, CDC; de Queiroz Oliveira, JA; Gonçalves, JE; Martins, MAP; Nobre, V; Pereira, FH; Simões E Silva, AC | 1 |
Fuhrman, DY; Joyce, EL; Kane-Gill, SL; Kellum, JA; Priyanka, P | 1 |
Abe, M; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Miki, H; Nakamura, S; Okada, N; Takechi, K; Zamami, Y | 1 |
Inage, S; Ise, Y; Isoe, Y; Katayama, S; Morishima, M; Murakami, M; Nakamura, S; Nei, T; Okamoto, S; Uetake, S; Yamaguchi, A | 1 |
Nunez, M; Tuerff, D | 1 |
Li, D; Li, X; Liao, Y; Pan, C; Ren, Y; Shen, S; Wen, A; Zhang, Y | 1 |
Ide, N; Sato, S; Sawaguchi, K | 1 |
Avedissian, SN; Liu, J; Pais, GM; Rhodes, NJ; Scheetz, MH | 1 |
Arnaud, FCS; Libório, AB | 1 |
Abraham, M; Behmer Hansen, R; Gold, J; Lad, M; Mammis, A; Zhao, K | 1 |
Avedissian, SN; Chalkias, A; d'Aloja, E; Downes, KJ; Fitzgerald, JC; Gilchrist, A; Hiner, D; Liu, J; Locci, E; Lodise, TP; Pais, GM; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Xanthos, T; Zuppa, AF | 1 |
Cheung, BMY; Qi, Z; Qin, X; Tsoi, MF; Zhang, L; Zhao, X | 1 |
Alobaidi, MM; Alqudah, MA; Farah, RI; Hammad, Y; Isleem, UN; Yaghi, RT; Yasin, MS; Zughoul, BM | 1 |
Campanile, A; Ciarambino, T; Giannico, OV; Giordano, M; Para, O; Signoriello, G; Tirelli, P | 1 |
Darko, W; Fazili, T; Gilotra, T; Kufel, WD; Miller, CD; Probst, LA; Seabury, RW; Shakeraneh, P; Steele, JM; Wang, D | 1 |
Bradley, JS; Le, J; Levine, DP; Liu, C; Lodise, TP; Lomaestro, BM; Maples, HD; Mueller, BA; Pai, MP; Rodvold, KA; Rotschafer, JC; Rybak, MJ; Wong-Beringer, A | 1 |
Bellos, I; Karageorgiou, V; Pergialiotis, V; Perrea, DN | 1 |
Brunetti, L; Kim, HJ; Lee, DS; Lee, SM; Seong, YH; Song, JH; Suh, D; Suh, DC | 1 |
Avedissian, SN; Downes, KJ; Liu, J; Moorthy, GS; Pais, GM; Rhodes, NJ; Scheetz, MH; Zepcan, S | 1 |
Bastin, MT; Bissell, BD; Flannery, AH; Morris, PE; Neyra, JA | 1 |
Mitsuoka, M; Miwa, R; Sakai, Y; Watanabe, H | 1 |
Ahmad, N; Cooper, R; Moudgil, H; Mukit, W | 1 |
Blair, K; Covington, EW | 1 |
Becker, A; Braun, E; Chaudier, P; Chidiac, C; Corbin, K; Dupieux, C; Ferry, T; Fessy, MH; Goutelle, S; Gunst, S; Laurent, F; Lustig, S; Mabrut, E; Triffault-Fillit, C; Valour, F | 1 |
Hay, K; Lavana, J; McNamara, JF; O'Callaghan, K | 1 |
Bellos, I; Daskalakis, G; Pergialiotis, V | 1 |
Chen, N; Liu, Y; Lv, M; Ma, S; Yu, Z | 1 |
De Bels, D; Honore, PM; Redant, S | 1 |
Courter, J; Dahale, D; Danziger-Isakov, L; Demmel, K; Geller, J; Goldstein, SL; Haslam, DB; O'Brien, M; Young, J | 1 |
Blyth, DM; Campbell, WR; Ganesan, A; Petfield, JL; Robben, PM; Shaikh, F; Stewart, L; Tribble, DR; Yabes, JM | 1 |
Deng, Y; Wang, Y; Yang, J; Zhan, H; Zhang, S | 1 |
Badri, S; Khorvash, F; Meidani, M; Sayadi, M; Soltani, R; Taheri, S | 1 |
Hagiya, H; Haruki, M; Haruki, Y; Inoue, Y; Sugiyama, T | 1 |
DeMott, JM; Hammond, DA; Peksa, GD; Traversa, A | 1 |
Huang, DB; Lodise, TP; Patel, N; Sangiovanni, RJ; Stornelli, N | 1 |
Cole, M; Covert, KL; Knoetze, D; Lewis, P | 1 |
Ko, WJ; Lin, SY; Shen, LJ; Wu, CC; Wu, FL; Wu, VC | 1 |
Bress, J; Hite, MS; Rider, TR; Silinskie, KM | 1 |
Autry, EB; Beckman, EJ; Gardner, BM; Kuhn, RJ; Saad, A; Schadler, A; Studtmann, AE; Wurth, MA; Young, MR | 1 |
Kaffenberger, BH; Milani-Nejad, N; Trinidad, J | 1 |
Brüggemann, RJ; de Wildt, SN; Kolwijck, E; Kramers, C; Schouten, JA; Workum, JD | 1 |
Hrabovsky, V; Kacirova, I; Kanova, M; Klementa, V; Martinek, A; Petejova, N; Sigutova, R; Stejskal, D; Svagera, Z; Zadrazil, J | 1 |
Gaggl, M; Kshirsagar, AV; Layton, JB; Pate, V; Stürmer, T | 1 |
Isobe, M; Kato, S; Konuma, T; Oiwa-Monna, M; Takahashi, S; Tojo, A; Yasu, T | 1 |
Kanaan, HD; Li, W; Pancioli, T; Zhang, PL | 1 |
Chen, J; Gao, P; Jia, G; Tao, F; Wang, Y; Yuan, S; Zhang, F; Zhang, H | 1 |
Bolaris, M; Fong, G; Gong, CL; Kang, A; Lee, BV; Lee, G; Minejima, E; Neely, M | 1 |
Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K | 1 |
Edwards, JD; Muklewicz, JD; Steuber, TD | 1 |
Egge, JA; Heintz, BH; Lee, JD; Livorsi, DJ; Lund, BC; Mosher, HJ | 1 |
Chew, R; Cox, M; Gregory, S; Paviour, S | 1 |
Huntul, MA; Kabli, NA; Thabit, AK; Tookhi, RF | 1 |
Goel, AP; Pradhan, S; Sahoo, RR; Wakhlu, A | 1 |
Crass, RL; He, M; Matvekas, A; Pai, MP; Souza, E | 1 |
Enoki, Y; Fujii, S; Hamada, Y; Kimura, T; Kojima, N; Matsumoto, K; Mizukami, Y; Moriyama, H; Oda, K; Osa, S; Taguchi, K; Takahashi, Y; Takesue, Y; Tashiro, S; Tsutsuura, M | 1 |
Canouï, E; Chouchana, L; Contejean, A; Kerneis, S; Tisseyre, M; Treluyer, JM | 1 |
Lin, FJ; Shao, CH; Tai, CH; Wang, CC; Wang, JT; Wu, CC | 1 |
Bellos, I; Pergialiotis, V; Perrea, DN | 1 |
Blair, M; Côté, JM; Cotter, A; Lynch, B; Murray, PT; Redahan, L | 1 |
Cole, JL; Eads, AV | 1 |
Joseph, K; Lui, M; Madison, G; Ramireddy, K; Turco, T | 1 |
Abdel, MP; Berry, DJ; Dagneaux, L; Leung, N; Limberg, AK; Osmon, DR | 1 |
Ang, LW; Chan, CP; Looi, WL; Lye, DC; Ooi, XY; See, YP; Yeo, SC; Young, BE | 1 |
Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA | 1 |
Acharya, A; Amato, J; Awdishu, L; Bal, S; Carrillo-Terrazas, M; Cerda, J; Gonzalez, DJ; Jani, V; Joy, MS; Le, A; Macedo, E; Mehta, R; Mills, RH; Nicoletti, P; RamachandraRao, SP; Tolwani, A; Vaingankar, S | 1 |
Ber Ce, P; Bhasin, B; Chhabra, S; D'Souza, A; Szabo, A | 1 |
Clark, M; Cole, JL; O'Glee, R; White, M | 1 |
Gong, Y; Lao, DH; Lu, YH; Shi, XP; Wang, T; Xu, Q; Zhang, M | 1 |
Akova, M; Aslan, AT; Dağ, O; Pashayev, T | 1 |
Burdette, SD; Elliott, BP; Madden, JA; Markert, RJ; Pleiman, CM; Speelmon, EC; Tang, MM | 1 |
Goldman, JL; Tillman, EM | 1 |
Awaya, M; Ikeda, H; Kusunoki, Y; Sasaki, T; Suzuki, A; Tanaka, H; Tanaka, N; Tanaka, S; Tomura, K; Watanabe, T; Yamauchi, R | 1 |
Berends, SE; de Jong, MD; Hakkens, N; Hodiamont, CJ; Juffermans, NP; Mathôt, RAA; van Hest, RM; van Vessem, DJ | 1 |
Avedissian, SN; Davis, JS; Holland, T; Lamar, PC; Liu, J; Lodise, TP; Neely, M; O'Donnell, JN; Pais, GM; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Tong, SYC | 1 |
Chen, CC; Huang, CC; Lin, YC; Wang, ST | 1 |
Imai, T; Kakeya, H; Kawaguchi, H; Nagayama, K; Nakamura, Y; Oshima, K; Sakurai, N; Shibata, W; Yamada, K; Yamashita, Y; Yano, T | 1 |
Imai, S; Ishibe, K; Itohara, K; Matsubara, K; Nakagawa, S; Nakagawa, T; Osada, Y; Shimazaki, A; Takao, S; Yonezawa, A | 1 |
Duong, L; Harriott, NG; Ives, AL; Pan-Chen, S; Rungkitwattanakul, D | 1 |
Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K; Yagi, T | 1 |
Daher, EF; Leite, TT; Parente Filho, SLA; Reis, ADF; Rocha, CVO; Silva Junior, GBD; Soares, DS | 1 |
Glassman, AH; Gogineni, HC; Jiang, EX; Magnussen, RA; Mayerson, JL; Scharschmidt, TJ | 1 |
Manian, FA | 1 |
Kaye, KS; Navalkele, B; Pogue, JM | 1 |
Cui, Y; Li, H; Li, X; Ma, L; Pan, K; Xiang, Q; Yang, L; Zhou, Y | 1 |
LeCleir, LK; Pettit, RS | 1 |
Farber, JL; Filippone, EJ; Kraft, WK | 1 |
Hincapie Castillo, J; Jeon, N; Klinker, KP; Staley, B; Winterstein, AG | 1 |
Gil, HW; Hwang, HS; Im, DS; Jung, SY; Shin, HJ; Song, HY; Yang, KJ | 1 |
Chen, A; Cunn, G; Geller, JA; Herschmiller, T; Murtaugh, T | 1 |
Branch-Elliman, W; Gupta, K; Itani, KMF; O'Brien, WJ; Perencevich, E; Ripollone, JE; Schweizer, ML; Strymish, J | 1 |
Avedissian, S; Catovic, L; Cluff, C; Griffin, B; Gulati, A; Joshi, MD; Liu, J; Lodise, TP; Miglis, CM; O'Donnell, JN; Pais, G; Prozialeck, W; Rhodes, NJ; Scheetz, MH | 1 |
Briyal, S; Cluff, C; Day, JZ; Gulati, A; Joshi, MD; Lamar, PC; Lodise, TP; Miglis, CM; O'Donnell, JN; Pais, G; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Venkatesan, N | 1 |
Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM | 1 |
Duman, D; Francisconi, R; Frederick, CA; Fusco, NM; Meaney, CJ; Prescott, WA | 1 |
Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ | 1 |
Chan, TM; Choy, BY; Kwan, LP; Mok, MM | 1 |
Ariyoshi, N; Fujishiro, T; Hattori, N; Ishii, I; Ishikawa, M; Matsubara, H; Miyauchi, H; Oami, T; Oda, S; Suzuki, T; Takatsuka, H; Yamazaki, S | 1 |
Okon, EE; Pingili, CS | 1 |
Awdishu, L | 1 |
Bryan, M; Cowden, C; Downes, KJ; Fisher, BT; Goldstein, SL; Gong, W; Huang, YS; Laskin, BL; Zaoutis, TE | 1 |
Dong, Z; Li, H; Qiu, S; Wang, J; Xiang, X; Zhang, D | 1 |
Cheng, DH; Guo, Q; Jing, L; Liu, TT; Lu, H; Pang, HM; Qin, XL; Wei, WX | 1 |
Caffrey, AR; Dosa, D; LaPlante, KL; Lodise, TP; Luther, MK; Timbrook, TT | 1 |
Elder, K; Hickerson, WL; Hill, DM | 1 |
Abouelkheir, M; Alsubaie, S | 1 |
Beckman, EJ | 1 |
Gaur, AH; Huskey, RL; Inaba, H; Ribeiro, R; Rubnitz, JE; Sun, Y; Tang, L; Wolf, J | 1 |
Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
Ahmad, I; Bech, CF; Clemmons, AB; Pantin, J | 1 |
Bouderlique, É; Duval, M; Frimat, M; Glowacki, F; Hazzan, M; Noël, C; Provôt, F; Saint-Jacques, C; Zaworski, J | 1 |
Englberger, L; Marschall, J | 1 |
Sartipy, U | 1 |
Bergstrom, C; Gupta, A; Nagalla, S | 2 |
Bartel, BJ; Catlin, JS; Gilder, RE; Kramer, CJ; Mullins, BP | 1 |
Downes, KJ; Fisher, BT; Laskin, BL | 1 |
Jhaveri, R; Willis, ZI | 1 |
Della Valle, CJ; Edelstein, AI; Okroj, KT; Rogers, T; Sporer, SM | 1 |
Kawanishi, K; Kodama, M; Koike, J; Mitobe, M; Mochizuki, T; Morikawa, S; Nagashima, Y; Nakano, T; Nitta, K; Ohara, M; Sawada, A; Taneda, S | 1 |
Banerjee, R; Cook, KM; Gillon, J; Grisso, AG; Jimenez-Truque, N; Phillips, EJ; Van Driest, SL | 1 |
Luque, Y; Mesnard, L | 1 |
Cao, L; Chen, C; Chen, ZZ; Dai, PF; Li, XY; Lv, QZ; Pan, KM; Wu, W; Wu, Y; Xu, JA; Xu, Q | 1 |
Arıcı, M; Balcı, C; Hayran, SA; Ünal, S; Uzun, Ö; Yüce, D | 1 |
Alzubaidi, M; Arthur, JM; Bhasin, B; Karakala, N; Kaushal, A; Nesbit, RM; Obadan, NO; Phadke, GM; Sachdev, SH; Velez, JCQ | 1 |
Burgess, DS; Rutter, WC | 2 |
Baumgartner, C; Child, J; Hurst, AL; MacBrayne, CE | 1 |
Chen, XY; Hu, CY; Liu, Y; Xie, XF; Xu, RX; Zhou, X | 1 |
Cheong, HI; Choi, YH; Ha, IS; Jung, AH; Jung, SH; Kang, HG; Kim, SJ; Lee, B; Park, J; Park, JD | 1 |
Krawczeski, CD; Kwiatkowski, DM; Montez-Rath, ME; Sutherland, SM; Uber, AM | 1 |
Leong, D; Wu, PE | 1 |
Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E | 1 |
Huang, D; Lodise, T; Patel, N | 1 |
Barreto, EF; Kashani, KB; Mara, KC; Nelson, S; Personett, HA; Rule, AD; Sakhuja, A; Schreier, DJ; Steckelberg, JM; Tande, AJ; Tootooni, MS | 1 |
Crass, RL; Dunn, R; Hong, J; Krop, LC; Pai, MP | 1 |
Asundi, A; Barón, AE; Branch-Elliman, W; Gold, H; Gupta, K; Ho, PM; Mehta, P; Mull, H; Stanislawski, M | 1 |
Akcan-Arikan, A; Dutta, A; Galati, M; Kam, C; Moffett, BS; Morris, J | 1 |
Hickerson, WL; Hill, DM; Lanfranco, J; Romero Legro, I; Sinclair, SE; Velamuri, SR | 1 |
Fang, F; Li, H; Li, X; Pan, J; Wu, D; Xiong, L; Xu, X; Zhang, D; Zheng, P; Zhou, Y | 1 |
Chang, AR; Coresh, J; Grams, ME; Inker, LA; Secora, A; Shin, JI; Wu, A; Zonozi, R | 1 |
Beyda, ND; Bowers, DR; Casapao, AM; Dilworth, TJ; Ibrahim, OM; Jacobs, DM; Mercier, RC | 1 |
Akbilgic, O; Gyamlani, G; Kalantar-Zadeh, K; Kovesdy, CP; Molnar, MZ; Naseer, A; Potukuchi, PK; Soohoo, M; Streja, E; Sumida, K; Thomas, F | 1 |
Aljefri, DM; Avedissian, SN; Nguyen, K; Postelnick, MJ; Rhodes, NJ; Scheetz, MH | 1 |
Cheng, H; Cheng, XL; Dong, YL; Dong, YZ; Li, Y; Wang, AM; Zhang, T; Zhang, Y | 1 |
Chen, AF; Cunn, GJ; Geller, JA; Herschmiller, TA; Murtaugh, TS | 1 |
Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S | 1 |
Hays, WB; Tillman, E | 1 |
Duncan, ST; Hamilton, DH; Jacobs, CA; King, JD; Shrout, MA; Womble, TN | 1 |
Downes, KJ; Fitzgerald, JC; Furth, SL; Himebauch, AS; Reedy, MD; Scheetz, MH; Thomas, NJ; Topjian, AA; Zane, NR; Zuppa, AF | 1 |
Azeredo, FJ; Bastos, REA; Bidu, NS; Couto, RD; Dias, EJC; Fernandes, BJD; Filho, JNC; Godoy, ALPC; Pedreira, JNR | 1 |
Boslett, BA; Chung, SA; Geha, RM; Manesh, R; Minter, DJ; Ramani, B | 1 |
Banerjee, R; Esbenshade, AJ; Quach, HT; Zhao, Z | 1 |
Avedissian, SN; Becher, L; Gulati, A; Hope, W; Joshi, MD; Lamar, PC; Liu, J; Lodise, TP; O'Donnell, JN; Pais, GM; Prozialeck, WC; Scheetz, MH | 1 |
Colson, P; Daures, JP; David, H; Eliet, J; Gaudard, P; Morquin, D; Saour, M; Villiet, M | 1 |
Chang, MJ; Han, E; Kang, S; Park, J; Park, MS; Yu, YM | 1 |
Baskol, G; Bayram, A; Deniz, K; Erkan, GN; Esmaoglu, A; Talih, G; Yildiz, K | 1 |
Andreolio, C; Antonacci Carvalho, PR; da Rocha, TS; Feiten, HDS; Martinbiancho, JK; Okumura, LM; Pedro Piva, J | 1 |
Akalya, K; Chua, HR; Da, Y; Lau, T; Lim, HN; Low, S; Murali, T; Ong, L; Tan, CS; Teo, BW; Vathsala, A | 1 |
Juang, P; Kollef, MH; Micek, ST | 1 |
Barreto, EF; Rule, AD; Schreier, DJ | 1 |
Anderson, C; Hersh, AL; Olson, J; Sorensen, J; Thorell, EA; Zobell, J | 1 |
Buhlinger, KM; Faircloth, CB; Fuller, KA; Wallace, JR | 1 |
Burgess, DS; Hall, RG; Rutter, WC | 1 |
Connor, MJ; Davis, GA; Harned, KC; Paciullo, CA; Winstead, PS | 1 |
Adelaar, R; Bearman, G; Desai, P; Fulco, P; Mounasamy, V | 1 |
Lee, H; Machado, J; Paredes, A; Raszynski, A; Totapally, BR | 1 |
Abdelhadii, A; Beumier, M; Cianferoni, S; De Backer, D; Devigili, A; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
Cleveland, KO; Gelfand, MS | 1 |
Lodise, TP; Paterson, DL; van Hal, SJ | 2 |
Borobia, AM; Carcas, AJ; Frías, J; Jiménez, C; Krauel-Bidwell, L; Medrano, N; Ramírez, E; Selgas, R; Tong, HY | 1 |
Bukur, M; Ley, EJ; Liou, DZ; Margulies, DR; Mirocha, J; Salim, A; Singer, MB; Srour, M | 1 |
Finnegan, PM; Hand, S; Linneman, TW; McDonald, JR; Moenster, RP; Thomas, Z | 1 |
Cappelletty, D; Jablonski, A; Jung, R | 1 |
Kamei, LK; Lopes, CK; Rigatto, MH; Rocha, JL; Tuon, FF; Zavascki, AP | 1 |
Jamal, JA; Lipman, J; Roberts, JA; Udy, AA | 1 |
Bayer, O; Breuel, H; Busch, M; Claus, RA; Otto, GP; Riedemann, NC; Schlattmann, P; Sossdorf, M | 1 |
Birch, A; Della Vecchia, BJ; Dupree, L; Gomes, DM; Jankowski, CA; Kraemer, DF; Smotherman, C | 1 |
Burgess, LD; Drew, RH | 1 |
Günzel, K; Nachtigall, I; Powollik, R; Spies, C; Tafelski, S; Tamarkin, A; Uhrig, A; Wernecke, KD | 1 |
Calderwood, MS; Kubiak, DW; Rostas, SE | 1 |
Dulhunty, JM; Hanrahan, TP; Harlow, G; Hutchinson, J; Lipman, J; Roberts, JA; Whitehouse, T | 1 |
Fadrowski, JJ; Lee, CK; McMunn, A; Milstone, AM; Sinclair, EA; Yenokyan, G | 1 |
Gutiérrez-Sánchez, MJ; Martín-Navarro, JA; Petkov-Stoyanov, V | 1 |
Burdmann, EA; Costa e Silva, VT; Marçal, LJ | 1 |
Anari, J; Courtney, PM; Lee, GC; Melnic, CM; Zimmer, Z | 1 |
Handler, SM; Kane-Gill, SL; Kellum, JA; Murugan, R; Sileanu, FE; Trietley, GS | 1 |
Cai, XZ; Zhu, HX | 1 |
Bachmeier, H; Flannery, AH | 1 |
Dulhunty, JM; Hanrahan, TP; Harlow, G; Lipman, J; Roberts, JA; Whitehouse, T | 1 |
Wongworawat, MD | 1 |
Bu, SH; Chen, JH; Chen, T; Li, LX; Liu, XZ; Liu, Y; Lu, XT; Yao, HJ; Yin, Y; Zhang, J | 1 |
de Carvalho Almeida, L; de Oliveira Dos Reis, C; Glesby, MJ; Kobayashi, CD; Rocha, PN; Santos, BM | 1 |
English, TM; McCreary, EK; Wargo, KA | 1 |
Hanrahan, T; Lipman, J; Roberts, JA; Whitehouse, T | 1 |
Gritzman, AL; Knoderer, CA; Nichols, KR; Wilson, AC | 1 |
Duszynska, W; Hurkacz, M; Kübler, A; Taccone, FS; Wiela-Hojenska, A | 1 |
Cava, L; Goolsby, TA; Hong, LT; Kiser, TH; Mueller, SW; Neumann, R; Reynolds, P; Sherman, DS | 1 |
Aeng, ES; Bowie, WR; Duncan, CP; Lau, TT; Li, G; Shalansky, KF; Zalunardo, N | 1 |
Bouman, CS; Juffermans, NP; van Hest, RM; van Vessem, DJ | 1 |
Hanrahan, TP; Kotapati, C; Lipman, J; Roberts, JA; Roberts, MJ; Rowland, J; Udy, A | 1 |
Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Hennessy, SA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
Ammann, H; Bernier-Jean, A; Bouchard, J; Brunette, V; Lavergne, V; Paquette, F; Pichette, V; Troyanov, S | 1 |
Balch, AH; Constance, JE; Korgenski, EK; Linakis, MW; Roberts, JK; Sherwin, CM; Spigarelli, MG; Stockmann, C; Ward, RM | 1 |
Getachew, H; Shibeshi, W; Tadesse, Y | 1 |
Anderson, AM; Easley, K; Kandiah, S; Kim, T; Patel, M; Rab, S; Wong, J; Xue, W | 1 |
Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A | 1 |
Adamson, R; Bauer, K; Bensman, J; Chaudhry, SB; Culshaw, DL; Eskandarian, R; Goff, DA; Lamp, KC; Leuthner, K; Lodise, T; McKinnell, JA; Moise, PA; Reyes, K; Smith, WJ; Virata, MD; Wong-Beringer, A; Zervos, MJ | 1 |
Askenazi, DJ; Hanna, MH; Selewski, DT | 1 |
Arcinue, R; Elkhwad, M; Kantak, A | 1 |
Fodero, KE; Horey, AL; Krajewski, MP; Mergenhagen, KA; Ruh, CA; Sellick, JA | 1 |
Chopra, A; Cies, JJ; Conley, SB; Moore, WS; Muneeruddin, S; Parker, J; Shea, P | 1 |
Heath, PT; Hill, LF; Lestner, JM; Sharland, M | 1 |
Cohen, H; Peyko, V; Smalley, S | 1 |
Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN | 1 |
Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
Barmparas, G; Chen, E; Harada, MY; Jay, J; Ko, A; Ley, EJ; Mason, R; Mehrzadi, D; Patel, B; Sun, BJ | 1 |
Cluff, C; Gulati, A; Lamar, PC; Lodise, TP; Neely, MN; O'Donnell, JN; Pais, G; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Venkatesan, N | 1 |
Al-Mohammad, A; Webb, PS | 1 |
Cohen, H; James, M; Millares-Sipin, CA; Smith, AP | 1 |
Bennett, WM | 1 |
Brimacombe, M; El Atrouni, W; Goodloe, N; Haidar, W; Hammoud, K; Yu, A | 1 |
Giuliano, CA; Kale-Pradhan, PB; Patel, CR | 1 |
Carreno, JJ; Davis, SL; Divine, G; Kenney, RM; Vazquez, JA | 1 |
Burgess, DR; Burgess, DS; Cox, JN; Martin, CA; Rutter, WC | 1 |
Nolin, TD | 1 |
Haikal, A; Hammoud, KA; Sinha Ray, A; Yu, ASL | 1 |
Chen, J; Li, H; Wang, J; Wang, S; Xiang, X; Zhang, D | 1 |
Gruneir, A; Howard, AW; Koren, G; Parshuram, CS; Rochon, PA; Slater, MB | 1 |
Evans, R; Hussain, T; Karino, S; Kaye, KS; Koons, J; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Perry, W; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
Dubrovskaya, Y; Louie, E; Mousavi, M; Papadopoulos, J; Scipione, MR; Zapolskaya, T | 1 |
Ghossein, C; Lertharakul, T; O'Donnell, JN; Peng, J; Pham, CK; Rhodes, NJ; Scheetz, MH | 1 |
Barreto, JN; Dierkhising, RA; Frazee, E; Kashani, KB; Kuper, PJ; Leung, N; Lieske, JC; Rule, AD; Virk, A | 1 |
Burgess, DR; Burgess, DS; Rutter, WC; Talbert, JC | 1 |
Bhargava, V; Fonseca, R; Malloy, M | 1 |
Bedos, JP; Bruneel, F; Caille, V; Eurin, M; Grimaldi, D; Lacave, G; Legriel, S; Palette, C | 1 |
Abrassart, S; Assal, M; Bernard, L; Djordjevic, M; Ferry, T; Roussos, C; Uçkay, I; Vaudaux, P; Vauthey, L | 1 |
Chou, NK; Hsueh, PR; Kuo, CC; Tsai, CW; Wang, SS; Wu, V | 1 |
Ariyoshi, N; Harigaya, K; Hattori, N; Kitada, M; Miura, G; Nakamura, H; Nakasa, H; Oda, S; Sadahiro, T; Shinozaki, K; Toyoda, A; Yamagata, S; Yamazaki, S | 1 |
Allon, M; Taylor, ME | 1 |
Deveikis, A; Hernandez, E; Jahng, M; Le, J; McKamy, S; Moriwaki, T | 1 |
Chow, SS; Ip, M; Lui, JW; You, JH | 1 |
Baker, C; Bayley, KB; Brown, A; Leggett, J; Pritchard, L; Sehdev, P | 1 |
Baum, M; Gattineni, J; Twombley, K | 1 |
Edwards, M; Kim, S; Moffett, BS | 1 |
Beringer, P; Choi, J; Lou, M; Minejima, E; Tse, E; Wong-Beringer, A | 1 |
Tang, RK; Tse, RK | 1 |
Chen, HY; Chen, TH; Chiang, YC; Shen, WC; Sue, YM; Tang, CH; Yu, FL | 1 |
Amann, K; Bröcker, EB; Müller, PA; Trautmann, A | 1 |
Biyani, M; Gupta, A; Khaira, A | 1 |
Goetz, MB; Graber, CJ; Prabaker, KK; Pratummas, T; Tran, TP | 1 |
Lee, SY; Park, HD; Seo, JY | 1 |
Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS | 1 |
Elola, M; Fuertes, A; Goenaga, MÁ; Ibarguren, M; Pérez, N | 1 |
Duricová, J; Grundmann, M; Kacířová, I; Martínek, A; Petejová, N; Plášek, J; Valkovský, I; Zahálková, J | 1 |
Matejovic, M; Radej, J | 1 |
Balkovetz, DF; Johnson, VA; Panwar, B; Patel, M | 1 |
Brozmannova, H; Duricova, J; Grundmann, M; Kacirova, I; Martinek, A; Petejova, N; Plasek, J; Urbanek, K; Zahalkova, J | 1 |
Ebihara, Y; Echizen, H; Kato, S; Kawakita, T; Mae, H; Nagamura, F; Ooi, J; Takahashi, S; Tojo, A; Tsuji, K | 1 |
Bellomo, R; Cole, L; Goldsmith, D; Morimatsu, H; Uchino, S | 1 |
Chen, DC; Du, B; Liu, DW | 1 |
Barit, G; Sakarcan, A | 1 |
Bensman, A; Deschênes, G; Ulinski, T | 1 |
Cleland, H; Richards, AL | 1 |
Gilliet, F; Marone, C; Zuliani, E; Zwahlen, H | 1 |
Bode-Böger, SM; Czock, D; Fliser, D; Hafer, C; Keller, F; Kielstein, JT; Kuse, E; Schöpke, T | 1 |
Dager, WE | 1 |
Assaly, R; Malhotra, D; Mauro, LS; Peloquin, CA; Schmude, K | 1 |
Allington, DR; Patrick, BN; Rivey, MP | 1 |
Fisher, DA; Goh, WP; Ingram, PR; Lye, DC; Tam, VH; Tambyah, PA | 1 |
Lindholm, DD | 1 |
Bodey, GP; Engineer, MS; Ho, DH | 1 |
Cao-Huu, T; Frimat, L; Hanesse, B; Hestin, D; Kessler, M | 1 |
Akiyama, K; Matsuda, N; Negishi, K; Oka, T; Shimamoto, K; Suetsugu, F; Takahashi, S; Toyama, A | 1 |
Ahn, SS; Gunter, MJ; Lazerson, J | 1 |
Davison, AM; Goutcher, E; Jeffrey, RF; Khan, AA; Prabhu, P; Todd, N; Will, EJ | 1 |
Carrel, T; Mihaljevic, T; Opravil, M; Pasic, M; Turina, M; von Segesser, L | 1 |
Murray, RP; Watson, RC | 1 |
Borner, K; Erdmann, K; Giehl, M; Hörstensmeyer, C; Keller, F; Looby, M; Pommer, W | 1 |
al-Dardiri, MM; el-Sayed, YM; Niazy, EM; Tawfik, AF | 1 |
Beaucaire, G; Beuscart, C; Georges, H; Guery, B; Leroy, O; Santré, C; Simon, M | 1 |
Brophy, DF; Mueller, BA | 1 |
Azar, R; Bakhache, E; Boldron, A | 1 |
Inui, K; Kokuryo, T; Nakamura, T; Takano, M | 1 |
Lew, SQ; Osman, BA | 1 |
Blankestijn, PJ; Boereboom, FT; Savelkoul, TJ; van Dijk, A; Ververs, FF | 1 |
Mueller, BA; Scott, MK; Sowinski, KM; Trujillo, TN; Venezia, RA | 1 |
Quigley, R; Shah, M | 1 |
Hiragi, T; Hiraoka, M; Mayumi, M; Ono, N; Osaka, Y; Tomida, N; Tsukahara, H | 1 |
Guérin, JM | 1 |
Bettington, H; Goldsmith, DJ; Pattison, JM; Sheerin, N; Tahir, H; Thomas, G | 1 |
Arisi, A; Beghi, C; Cabassi, A; Campodonico, R; Fiaccadori, E; Gherli, T; Maggiore, U | 1 |
Acartürk, E; Akgül, F; Paydaş, S | 1 |
Winter, RE | 1 |
Azadian, BS; Brown, EA; Davies, SP; Kox, WJ | 1 |
Brackett, CC | 1 |
Macias, WL; Mueller, BA; Scarim, SK | 1 |
Böhler, J; Keller, E; Kohler, C; Reetze-Bonorden, P; Schollmeyer, P | 1 |
Bellomo, R; Boyce, N; Ernest, D; Parkin, G | 1 |
Rawer, P; Seim, KE | 1 |
Collins, CH; Fitch, LE; George, RC; Gilfillan, AJ; Heptonstall, J; Johnson, AP; Morrison, D; Naidoo, J; Uttley, AH; Woodford, N | 1 |
Brill, JE; Busuttil, RW; Cherry, JD; Kuhls, TL; Leach, CT | 1 |
Charney, M; Knudson, P; Salcido, D | 1 |
Carbon, C; Vachon, F | 1 |
Lindholm, DD; Murray, JS | 1 |
41 review(s) available for vancomycin and Acute Kidney Injury
Article | Year |
---|---|
Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Drug Therapy, Combination; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin | 2021 |
Nephrotoxins and acute kidney injury - The consensus of the Taiwan acute kidney injury Task Force.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Anti-Bacterial Agents; Anticoagulants; Consensus; Contrast Media; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Retrospective Studies; Taiwan; Vancomycin | 2022 |
Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Humans; Vancomycin | 2022 |
Impact of pharmacist intervention in reducing vancomycin-associated acute kidney injury: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Creatinine; Humans; Pharmacists; Retrospective Studies; Vancomycin | 2023 |
Risk factors for vancomycin-associated acute kidney injury: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2022 |
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Electrolytes; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2022 |
Nephrotoxicity Related to Antibiotic-Loaded Spacers in a 2-Stage Revision for Periprosthetic Joint Infection.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bone Cements; Gentamicins; Humans; Prosthesis-Related Infections; Reoperation; Vancomycin | 2023 |
[Development of Novel Dosing Strategy According to the Area under the Concentration-Time Curve for Vancomycin].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Acute kidney injury in the context of staged revision arthroplasty and the use of antibiotic-laden cement spacers: a systematic review.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty; Humans; Tobramycin; Vancomycin | 2023 |
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult | 2020 |
Drug-induced acute kidney injury: diverse mechanisms of tubular injury.
Topics: Acute Kidney Injury; Humans; Kidney Tubules; Vancomycin | 2019 |
Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Baclofen; Brain Diseases; Electroencephalography; Fever; GABA-B Receptor Agonists; Humans; Infusion Pumps, Implantable; Infusions, Spinal; Male; Meropenem; Paraplegia; Seizures; Spasm; Spinal Cord Injuries; Vancomycin | 2020 |
Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin; Tazobactam; Vancomycin | 2020 |
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactams; Child; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Intensive Care Units; Network Meta-Analysis; Pseudomonas Infections; Vancomycin | 2020 |
Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Disease Models, Animal; Humans; Vancomycin | 2020 |
Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Humans; Infusions, Intravenous; Observational Studies as Topic; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
Relationship of vancomycin trough levels with acute kidney injury risk: an exposure-toxicity meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Humans; Retrospective Studies; Treatment Failure; Vancomycin | 2020 |
Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Risk; Vancomycin | 2020 |
Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Gentamicins; Humans; Kidney; MicroRNAs; Sepsis; Vancomycin | 2020 |
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Area Under Curve; Bacteremia; Drug Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Odds Ratio; Safety; Staphylococcal Infections; Treatment Failure; Vancomycin | 2021 |
Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Biopsy; Humans; Kidney; Prognosis; Vancomycin | 2022 |
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antimicrobial Stewardship; Creatinine; Critical Illness; Drug Therapy, Combination; Humans; Kidney Tubules; Nephritis; Patient Acuity; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2021 |
Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
The Nephrotoxicity of Vancomycin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2017 |
Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Male; Rats; Vancomycin | 2018 |
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies.
Topics: Acute Kidney Injury; Critical Illness; Disease Susceptibility; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Renal Replacement Therapy; Risk Factors; Vancomycin | 2017 |
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Adult; Critical Care; Drug Therapy, Combination; Humans; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Vancomycin | 2018 |
Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biopsy; Diabetes Mellitus, Type 1; Humans; Male; Nephritis, Interstitial; Vancomycin | 2018 |
Acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam administration: a systematic review and meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2018 |
Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Odds Ratio; Vancomycin | 2019 |
The successful use of vancomycin-impregnated cement beads in a patient with vancomycin systemic toxicity: a case report with review of literature.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Anti-Bacterial Agents; Bone Cements; Calcaneus; Debridement; Female; Humans; Naphthalenes; Osteomyelitis; Polymers; Vancomycin | 2013 |
Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2015 |
Drug-induced acute kidney injury in neonates.
Topics: Acute Kidney Injury; Acyclovir; Aminoglycosides; Amphotericin B; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Humans; Infant, Newborn; Vancomycin | 2016 |
Vancomycin toxicity in neonates: a review of the evidence.
Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Infant, Newborn; Mice; Vancomycin | 2016 |
Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2016 |
Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Administration, Intravenous; Anti-Bacterial Agents; Humans; Linezolid; Risk Factors; Vancomycin | 2016 |
Accidental and iatrogenic causes of acute kidney injury.
Topics: Acute Kidney Injury; Aminoglycosides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Contrast Media; Humans; Iatrogenic Disease; Vancomycin | 2011 |
Vancomycin nephrotoxicity: myths and facts.
Topics: Acute Kidney Injury; Animals; Humans; Risk Factors; Vancomycin | 2011 |
[An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Risk of vancomycin-induced nephrotoxicity in the population with chronic kidney disease.
Topics: Acute Kidney Injury; Humans; Population Surveillance; Renal Insufficiency, Chronic; Risk Factors; Vancomycin | 2013 |
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Kidney; Renal Dialysis; Vancomycin | 2013 |
14 trial(s) available for vancomycin and Acute Kidney Injury
Article | Year |
---|---|
Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Critical Illness; Female; Humans; Incidence; Length of Stay; Logistic Models; Magnesium Sulfate; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2021 |
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Clinical Evaluation of a Vancomycin Dosage Strategy Based on a Serum Trough Concentration Model in Elderly Patients with Severe Pneumonia.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Humans; Middle Aged; Pneumonia; Prospective Studies; Retrospective Studies; Vancomycin | 2023 |
Effect of N-acetylcysteine against Vancomycin-Induced Nephrotoxicity: A Randomized Controlled Clinical Trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Antioxidants; Blood Urea Nitrogen; Creatinine; Female; Humans; Male; Middle Aged; Reactive Oxygen Species; Vancomycin | 2020 |
Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Allografts; Autografts; Cefepime; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Survival Rate; Vancomycin | 2018 |
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.
Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin | 2019 |
Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Adult; Aged; Aminoglycosides; Amphotericin B; beta 2-Microglobulin; Biomarkers; Calcineurin Inhibitors; Chemokine CCL2; Clusterin; Cyclosporine; Cystatin C; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Male; Middle Aged; Tacrolimus; Vancomycin | 2019 |
Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Female; Humans; Infusions, Intravenous; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2015 |
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin | 2016 |
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT).
Topics: Academic Medical Centers; Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Substitution; Female; Humans; Incidence; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Vancomycin | 2017 |
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Critical Illness; Cystatin C; Drug Dosage Calculations; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Prospective Studies; Quality Improvement; Vancomycin | 2017 |
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Prospective Studies; Renal Dialysis; Risk Assessment; Thienamycins; Treatment Outcome; Vancomycin | 2006 |
A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.
Topics: Acute Kidney Injury; Creatinine; Hemofiltration; Humans; Molecular Weight; Renal Dialysis; Urea; Uric Acid; Vancomycin | 1994 |
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Topics: Acrylic Resins; Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hemofiltration; Humans; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure; Shock, Septic; Time Factors; Vancomycin | 1999 |
324 other study(ies) available for vancomycin and Acute Kidney Injury
Article | Year |
---|---|
Docosahexaenoic Acid-Acylated Astaxanthin Esters Exhibit Superior Renal Protective Effect to Recombination of Astaxanthin with DHA via Alleviating Oxidative Stress Coupled with Apoptosis in Vancomycin-Treated Mice with Nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Apoptosis; Aquatic Organisms; Disease Models, Animal; Docosahexaenoic Acids; Esters; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Protective Agents; Vancomycin | 2021 |
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bayes Theorem; Cefepime; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin | 2021 |
Vancomycin-induced nephrotoxicity in non-intensive care unit pediatric patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infant; Intensive Care Units; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Seoul; Tertiary Care Centers; Vancomycin; Young Adult | 2021 |
Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Vancomycin | 2022 |
Vancomycin Nephrotoxicity Causing Renal Transplant Acute Kidney Injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Kidney Transplantation; Retrospective Studies; Vancomycin | 2021 |
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin | 2022 |
Falsely Undetectable Vancomycin Levels in a Pediatric Patient With Chronic Granulomatous Disease.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Female; Granulomatous Disease, Chronic; Humans; Male; Retrospective Studies; Vancomycin | 2022 |
Risk of kidney injury in patients on concomitant oral vancomycin and piperacillin-tazobactam: Analysis of the pharmacovigilance database in Japan.
Topics: Acute Kidney Injury; Administration, Oral; Age Factors; Aged; Aged, 80 and over; Databases as Topic; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Pharmacovigilance; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sex Factors; Vancomycin | 2022 |
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin | 2021 |
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Impact of decreasing vancomycin exposure on acute kidney injury in stem cell transplant recipients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Vancomycin | 2022 |
Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Big Data; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Timely explantation of tobramycin-impregnated beads and bone cement to avoid haemodialysis in a patient with worsening renal failure.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bone Cements; Humans; Male; Prosthesis-Related Infections; Renal Dialysis; Tobramycin; Vancomycin | 2022 |
Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bayes Theorem; Coagulase; Electronic Health Records; Female; Humans; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pseudomonas; Retrospective Studies; Vancomycin | 2022 |
Expression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agents.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Circulating MicroRNA; Creatinine; Female; Gentamicins; Humans; Interleukin-6; Lipocalin-2; Male; MicroRNAs; Procalcitonin; Sepsis; Vancomycin | 2022 |
Severe AKI in a Patient on Multiple Antimicrobial Agents for Leg Infection.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Leg; Vancomycin | 2022 |
Comparison of single trough-based area under the concentration-time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Retrospective Studies; Vancomycin | 2022 |
Impact of combining vancomycin with proton pump inhibitors on the incidence of acute kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Incidence; Proton Pump Inhibitors; Retrospective Studies; Vancomycin | 2022 |
Antibacterial-associated acute kidney injury among older adults: A post-marketing surveillance study using the FDA adverse events reporting system.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Aged; Anti-Bacterial Agents; Bayes Theorem; Gentamicins; Humans; Sulfamethoxazole; Trimethoprim; United States; United States Food and Drug Administration; Vancomycin | 2022 |
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2022 |
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biomarkers; Cefepime; Creatinine; Critical Illness; Cystatin C; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Renal Dialysis; Retrospective Studies; Vancomycin | 2022 |
Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Hominidae; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels.
Topics: Acute Kidney Injury; Administration, Intravenous; Aged; Anti-Bacterial Agents; Drug Monitoring; Humans; Retrospective Studies; Vancomycin | 2022 |
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aorta; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thrombocytopenia; Vancomycin | 2022 |
Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin | 2023 |
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin | 2023 |
A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antimicrobial Stewardship; Humans; Infection Control; Japan; Methicillin-Resistant Staphylococcus aureus; Pharmacists; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by Service.
Topics: Acute Kidney Injury; Aminoglycosides; Child; Creatinine; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2022 |
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2022 |
Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Area Under Curve; Child; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2023 |
Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: CON.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Vancomycin | 2022 |
Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: PRO.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Vancomycin | 2022 |
Prevalence and risk factors associated with readmission with acute kidney injury in patients receiving vancomycin outpatient parenteral antimicrobial therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Outpatients; Patient Readmission; Penicillins; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Sepsis; Vancomycin | 2022 |
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Ceftazidime; Data Analysis; Drug Therapy, Combination; Female; Humans; Meropenem; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Efficacy and Safety of Vancomycin Bayesian-Estimated Area Under the Curve Versus Trough-Based Dosing.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2023 |
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult | 2023 |
Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model.
Topics: Acute Kidney Injury; Animals; Biomarkers; Humans; Kidney; Rats; Rats, Sprague-Dawley; Vancomycin | 2023 |
Nephrotoxin Exposure and Acute Kidney Injury in Adults.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Child; Hospitalization; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019-2020.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; COVID-19; Guideline Adherence; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2023 |
Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Enterococcus faecium; Glycopeptides; Humans; Propensity Score; Retrospective Studies; Teicoplanin; Vancomycin | 2023 |
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis.
Topics: Acute Kidney Injury; Animals; Mice; Toll-Like Receptor 4; Transcriptome; Vancomycin | 2023 |
Association of Acute Kidney Injury With Antibiotic Loaded Cement Used for Treatment of Periprosthetic Joint Infection.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Bone Cements; Diuretics; Humans; Prosthesis-Related Infections; Retrospective Studies; Treatment Outcome; Vancomycin | 2023 |
Biopsy-proven granulomatous interstitial nephritis associated with vancomycin in an adult patient: a case report.
Topics: Acute Kidney Injury; Adult; Aged; Female; Humans; Image-Guided Biopsy; Kidney; Nephritis, Interstitial; Vancomycin | 2023 |
Factors associated with acute kidney injury among preterm infants administered vancomycin: a retrospective cohort study.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Birth Weight; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Retrospective Studies; Vancomycin | 2023 |
Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Child; Cystic Fibrosis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2023 |
Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Drug Therapy, Combination; Glomerular Filtration Rate; Iohexol; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2023 |
Vancomycin Hydrochloride as a Risk Factor for Acute Kidney Injury: A Retrospective Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2023 |
Drug-drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports.
Topics: Acute Kidney Injury; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Japan; Sodium Potassium Chloride Symporter Inhibitors; Teicoplanin; Vancomycin | 2023 |
Intraarticular vancomycin decreased the risk of acute postoperative periprosthetic joint infection without increasing complication in primary total joint arthroplasty-a prospective study.
Topics: Acute Kidney Injury; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Humans; Ototoxicity; Prospective Studies; Prosthesis-Related Infections; Retrospective Studies; Vancomycin | 2023 |
Nephrotoxicity caused by colistin use in ICU: a single centre experience.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin | 2023 |
Recombinant Klotho alleviates vancomycin-induced acute kidney injury by upregulating anti-oxidative capacity via JAK2/STAT3/GPx3 axis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Humans; Janus Kinase 2; Mice; Reactive Oxygen Species; RNA, Small Interfering; STAT3 Transcription Factor; Vancomycin | 2023 |
Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Humans; Incidence; Prospective Studies; Retrospective Studies; Vancomycin | 2023 |
Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Brazil; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Prospective Studies; Vancomycin | 2019 |
Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2019 |
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Surveys and Questionnaires; Vancomycin | 2019 |
Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Cohort Studies; Critical Care; Humans; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
More Frequent Premature Antibiotic Discontinuations and Acute Kidney Injury in the Outpatient Setting With Vancomycin Compared to Daptomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2020 |
Development and Validation of a Risk Prediction Model of Vancomycin-Associated Nephrotoxicity in Elderly Patients: A Pilot Study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Comorbidity; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Risk Factors; Staphylococcal Infections; Vancomycin | 2020 |
[Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Doripenem; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk; Vancomycin | 2019 |
Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Vancomycin | 2020 |
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Models, Structural; Retrospective Studies; Vancomycin | 2020 |
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2020 |
Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Comorbidity; Creatinine; Diuretics; Female; Heart Failure; Hong Kong; Humans; Incidence; Infant; Infant, Newborn; Length of Stay; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency, Chronic; Respiratory Insufficiency; Risk Factors; Vancomycin; Young Adult | 2020 |
Determining the risk of acute kidney injury in patients who underwent total joint replacement: A retrospective study.
Topics: Acute Kidney Injury; Arthroplasty, Replacement, Hip; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Topics: Acute Kidney Injury; Anti-Infective Agents; Cohort Studies; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; New York; Outpatients; Propensity Score; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatr
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Drug Monitoring; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic; Staphylococcal Infections; United States; Vancomycin | 2020 |
The risk of vancomycin toxicity in patients with liver impairment.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Liver Diseases; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Serum; Staphylococcal Infections; Vancomycin; Young Adult | 2020 |
[Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute Kidney Injury: A Case Report].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections; Vancomycin | 2020 |
DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Eosinophilia; Female; Humans; Lung Abscess; Smokers; Vancomycin | 2020 |
Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2020 |
Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cohort Studies; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Critical Care; Duration of Therapy; Female; Humans; Intensive Care Units; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Effective treatment of vancomycin nephrotoxicity with continuous venous-venous haemodiafiltration (CVVHDF) in a paediatric patient.
Topics: Acute Kidney Injury; Child, Preschool; Creatinine; Hemodiafiltration; Humans; Male; Vancomycin | 2020 |
Continuous Versus Intermittent Infusion of Vancomycin: Toward the End of the Controversy or Even Closer to the Swan Song?
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Vancomycin | 2020 |
Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Databases, Factual; Febrile Neutropenia; Female; Humans; Infant; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Lactams; Piperacillin; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2021 |
The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; China; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Japan; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Humans; Incidence; Patient Readmission; Retrospective Studies; Risk Factors; Vancomycin; Veterans | 2020 |
Pharmacokinetics and dosing of vancomycin in patients undergoing sustained low efficiency daily diafiltration (SLEDD-f): A prospective study.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Critical Illness; Humans; Hybrid Renal Replacement Therapy; Prospective Studies; Vancomycin | 2021 |
Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Middle Aged; Renal Dialysis; Vancomycin | 2020 |
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Female; Humans; Incidence; Infant; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult | 2020 |
Acute kidney injury in vancomycin-induced drug reaction with eosinophilia and systemic symptoms: A case-control study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Vancomycin | 2023 |
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
The comparative risk of acute kidney injury of vancomycin relative to other common antibiotics.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Duration of Therapy; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Middle Aged; Vancomycin | 2020 |
Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantation.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cord Blood Stem Cell Transplantation; Humans; Retrospective Studies; Vancomycin | 2021 |
Electron microscopic findings can support multiple etiologies of nephrotoxicity in renal tubules.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Female; Gastrointestinal Agents; Humans; Kidney Tubules; Male; Middle Aged; Vancomycin | 2020 |
Baseline kidney function is associated with vancomycin-induced acute kidney injury in children: a prospective nested case-control study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Child; Humans; Kidney; Prospective Studies; Retrospective Studies; Vancomycin | 2021 |
Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cost-Benefit Analysis; Humans; Microbial Sensitivity Tests; Vancomycin | 2021 |
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Evaluation of area under the concentration-time curve-guided vancomycin dosing with or without piperacillin-tazobactam on the incidence of acute kidney injury.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Area Under Curve; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Clostridioides; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
When fever is more than infection: two cases of vancomycin-induced drug reaction with eosinophilia and systemic symptoms (DRESS).
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity Syndrome; Female; Fever; Glucocorticoids; Humans; Male; Middle Aged; Vancomycin | 2021 |
Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2021 |
Staphylococcus-associated acute glomerulonephritis in a patient with dermatomyositis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Dermatomyositis; Endocarditis, Bacterial; Fatal Outcome; Glomerulonephritis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Staphylococcal Infections; Vancomycin | 2021 |
Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Pharmacovigilance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam.
Topics: Acute Kidney Injury; Humans; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Vancomycin | 2022 |
Efficacy and Safety of Vancomycin Therapy After the Transition to AUC/MIC Monitoring in a Primary Facility.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Creatinine; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Comorbidity; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hospitals, Community; Humans; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pharmacists; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2021 |
Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers: Incidence, Risks, and Outcomes.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bone Cements; Creatinine; Disease Progression; Drug Implants; Female; Follow-Up Studies; Gentamicins; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Odds Ratio; Prosthesis-Related Infections; Renal Insufficiency, Chronic; Retrospective Studies; Risk; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin | 2021 |
Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Comorbidity; COVID-19; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoxia; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study.
Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin | 2021 |
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury.
Topics: Acute Kidney Injury; Adult; Biomarkers; Chromatography, Liquid; Creatinine; Exosomes; Humans; Inflammation; Male; Middle Aged; Proteomics; Tandem Mass Spectrometry; Vancomycin; Young Adult | 2021 |
Correlates and Outcomes of Early Acute Kidney Injury after Hematopoietic Cell Transplantation.
Topics: Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Aged; Anti-Bacterial Agents; Case-Control Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2021 |
Transitioning From Consult-Based to Automatic Pharmacy-Driven Vancomycin Management: Results From a Single, Primary Care Center.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Monitoring; Humans; Pharmacy; Primary Health Care; Retrospective Studies; Vancomycin | 2022 |
Vancomycin-induced acute kidney injury after liver transplantation.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Female; Humans; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Vancomycin | 2021 |
Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Kidney; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Tertiary Care Centers; Vancomycin | 2021 |
A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Safety of vancomycin in patients with moderate and severe renal dysfunction.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Kidney; Retrospective Studies; Vancomycin | 2021 |
Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Incidence; Retrospective Studies; Vancomycin | 2021 |
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Area Under Curve; Prospective Studies; Rats; Vancomycin | 2021 |
Temporal Trends of Acute Kidney Injury and Associated Risk Exposures in Extremely Preterm Infants.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Female; Gestational Age; Humans; Incidence; Infant, Extremely Premature; Infant, Newborn; Intensive Care, Neonatal; Male; Patient Transfer; Premature Birth; Risk Factors; Sepsis; Taiwan; Vancomycin | 2021 |
Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood Glucose; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Glucose-6-Phosphatase; Kidney; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvic Acid; Reperfusion Injury; Vancomycin | 2021 |
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Brazil; Critical Illness; Cross-Sectional Studies; Female; Humans; Incidence; Male; Middle Aged; Polymyxin B; Risk Factors; Vancomycin | 2017 |
Acute Kidney Disease After Total Hip and Knee Arthroplasty: Incidence and Associated Factors.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Body Mass Index; Female; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2017 |
Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well?
Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin | 2017 |
Reply to Manian.
Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin | 2017 |
Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Risk Factors; Vancomycin | 2017 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2017 |
Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
Topics: Acute Kidney Injury; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Proliferation; Cilastatin; Cytoprotection; Dose-Response Relationship, Drug; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Time Factors; Vancomycin | 2017 |
Acute Kidney Injury After First-Stage Joint Revision for Infection: Risk Factors and the Impact of Antibiotic Dosing.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Female; Humans; Incidence; Knee Joint; Male; Middle Aged; New York; Odds Ratio; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult | 2017 |
Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Clostridioides difficile; Clostridium Infections; Cohort Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surgical Wound Infection; United States; United States Department of Veterans Affairs; Vancomycin | 2017 |
24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Area Under Curve; Biomarkers; Cell Adhesion Molecules; Clusterin; Cystatin C; Lipocalin-2; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Vancomycin | 2017 |
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin | 2017 |
Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Cohort Studies; Cystic Fibrosis; Female; Humans; Linear Models; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multivariate Analysis; Respiratory Function Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult | 2017 |
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Acute kidney injury in a renal transplant recipient due to concomitant use of vancomycin and foscarnet.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antiviral Agents; Foscarnet; Humans; Kidney Transplantation; Male; Vancomycin | 2017 |
An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
Topics: Acute Kidney Injury; Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Biological Availability; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Intestine, Large; Male; Middle Aged; Rectal Neoplasms; Renal Replacement Therapy; Respiration, Artificial; Sepsis; Vancomycin | 2017 |
Vancomycin-Induced Leukocytoclastic Vasculitis and Acute Renal Failure Due to Tubulointerstitial Nephritis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Humans; Male; Nephritis, Interstitial; Vancomycin; Vasculitis, Leukocytoclastic, Cutaneous | 2017 |
Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Factual; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; United States; Vancomycin | 2017 |
MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.
Topics: Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle Proteins; Cell Line, Transformed; CpG Islands; Cytoskeletal Proteins; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation; Humans; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microphthalmia-Associated Transcription Factor; MicroRNAs; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA Interference; RNA, Small Interfering; Tumor Suppressor Protein p53; Vancomycin | 2017 |
Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.
Topics: Acute Kidney Injury; Adult; Aged; Biomarkers; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Lipocalin-2; Male; Middle Aged; Prospective Studies; ROC Curve; Sensitivity and Specificity; Vancomycin | 2017 |
Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Body Surface Area; Burns; Creatinine; Female; Humans; Male; Middle Aged; Retrospective Studies; Smoke Inhalation Injury; Trauma Severity Indices; Vancomycin | 2018 |
Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2018 |
Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up?
Topics: Acute Kidney Injury; Child; Critical Illness; Humans; Piperacillin; Tazobactam; Vancomycin | 2017 |
Adverse Effects of Intravenous Vancomycin-Based Prophylaxis during Therapy for Pediatric Acute Myeloid Leukemia.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Vancomycin | 2018 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Humans; Male; Renal Dialysis; Vancomycin | 2018 |
Reply to Sartipy.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Humans; Vancomycin | 2018 |
Vancomycin prophylaxis and acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Humans; Sternum; Vancomycin; Wound Infection | 2018 |
Management of Patients With Febrile Neutropenia: A Teachable Moment.
Topics: Acute Kidney Injury; Administration, Intravenous; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluoroquinolones; Hospitalization; Humans; Medical Overuse; Neoplasm Staging; Piperacillin, Tazobactam Drug Combination; Risk Assessment; Vancomycin | 2018 |
Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply.
Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin | 2018 |
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment.
Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin | 2018 |
Nephrotoxicity After the Treatment of Periprosthetic Joint Infection With Antibiotic-Loaded Cement Spacers.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Creatinine; Female; Gentamicins; Humans; Illinois; Incidence; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Reoperation; Risk Factors; Tobramycin; Vancomycin | 2018 |
Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Multivariate Analysis; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Vancomycin | 2019 |
[Vancomycin nephrotoxicity: Frequency and mechanistic aspects].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Kidney; Risk Factors; Vancomycin | 2018 |
Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Monitoring; Female; Hospitalization; Humans; Hyperuricemia; Incidence; Kidney; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin; Vasoconstrictor Agents | 2018 |
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Logistic Models; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Thienamycins; Vancomycin | 2018 |
Vancomycin-Associated Acute Kidney Injury with a Steep Rise in Serum Creatinine.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cohort Studies; Colorimetry; Creatinine; Female; Humans; Male; Mass Spectrometry; Middle Aged; Vancomycin | 2018 |
Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2018 |
Experience with Continuous Infusion Vancomycin Dosing in a Large Pediatric Hospital.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Infusions, Intravenous; Kidney; Male; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Female; Hemodiafiltration; Humans; Infant; Male; Metabolic Clearance Rate; Oliguria; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
Topics: Acute Kidney Injury; Adolescent; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Critical Illness; Enalapril; Female; Heart Defects, Congenital; Humans; Ibuprofen; Infant; Ketorolac; Male; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Vancomycin | 2018 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult | 2018 |
Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cost Savings; Folic Acid Antagonists; Hospitalization; Humans; Pyrimidines; Skin Diseases, Infectious; Vancomycin | 2018 |
Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Female; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Pseudomonas Infections; Severity of Illness Index; Vancomycin | 2019 |
Dosing vancomycin in the super obese: less is more.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Body Weight; Creatinine; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Nomograms; Obesity; Staphylococcal Infections; Vancomycin; Young Adult | 2018 |
Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridium Infections; Female; Hospitals, Veterans; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Proportional Hazards Models; Prosthesis-Related Infections; Quality Improvement; Time Factors; United States; Vancomycin | 2018 |
Vancomycin associated acute kidney injury in pediatric patients.
Topics: Acetazolamide; Acute Kidney Injury; Child; Child, Preschool; Clindamycin; Female; Hospital Mortality; Humans; Infant; Intensive Care Units, Pediatric; Kidney; Logistic Models; Male; Nafcillin; Respiration, Artificial; Retrospective Studies; Risk Factors; Vancomycin | 2018 |
Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Algorithms; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Cohort Studies; Continuous Renal Replacement Therapy; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Retrospective Studies; Sex Factors; Vancomycin; Young Adult | 2019 |
Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-δ.
Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy; Autophagy-Related Protein 7; Cell Line; Enzyme Activation; Gene Expression Profiling; Gene Ontology; Humans; Kidney Tubules; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Protein Kinase C-delta; TOR Serine-Threonine Kinases; Vancomycin | 2019 |
Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.
Topics: Acute Kidney Injury; Administration, Intravenous; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Hospital Mortality; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Vancomycin | 2019 |
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Observational Studies as Topic; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Daptomycin; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; United States; United States Department of Veterans Affairs; Vancomycin; Veterans | 2019 |
Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem.
Topics: Acute Kidney Injury; Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Meropenem; Retrospective Studies; Vancomycin | 2019 |
Response to Letter to the Editor: Acute Kidney Injury After First-Stage Joint Revision for Infection: Risk Factors and the Impact of Antibiotic Dosing.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Reoperation; Risk Factors; Vancomycin | 2019 |
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin | 2019 |
Vancomycin-Associated Acute Kidney Injury in Critically Ill Adolescent and Young Adult Patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Critical Illness; Humans; Retrospective Studies; Vancomycin; Young Adult | 2020 |
Greater Rates of Acute Kidney Injury in African American Total Knee Arthroplasty Patients.
Topics: Acute Kidney Injury; Adult; Aged; Antimicrobial Stewardship; Arthroplasty, Replacement, Knee; Black or African American; Creatinine; Female; Hispanic or Latino; Hospitalization; Hospitals; Humans; Male; Middle Aged; Osteoarthritis, Knee; Postoperative Period; Preoperative Period; Prevalence; Prosthesis-Related Infections; Retrospective Studies; Vancomycin; White People | 2019 |
Vancomycin Prescribing and Therapeutic Drug Monitoring in Children With and Without Acute Kidney Injury After Cardiac Arrest.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Monitoring; Drug Prescriptions; Female; Glomerular Filtration Rate; Heart Arrest; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Vancomycin | 2019 |
The Right Frame.
Topics: Acute Kidney Injury; Aged; Agriculture; Anti-Bacterial Agents; California; Contrast Media; Cough; Diagnosis, Differential; Dyspnea; Fever; Granulomatosis with Polyangiitis; Humans; Lung Neoplasms; Male; Mexico; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tomography, X-Ray Computed; Vancomycin | 2019 |
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
Topics: Acute Kidney Injury; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biomarkers; Cell Adhesion Molecules; Chromatography, Liquid; Clusterin; Male; Osteopontin; Plasma; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Vancomycin | 2019 |
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Critical Illness; Daptomycin; Endocarditis; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Odds Ratio; Propensity Score; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2019 |
Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit.
Topics: Acute Kidney Injury; Adult; beta-Lactams; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Risk Factors; Survival Analysis; Vancomycin | 2019 |
The alpha-2 receptor agonist dexmedetomidine attenuates vancomycin‑induced acute kidney injury.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Bacterial Agents; Dexmedetomidine; Rats; Rats, Wistar; Vancomycin; Vasoconstriction | 2019 |
Vancomycin-associated Nephrotoxicity and Risk Factors in Critically Ill Children Without Preexisting Renal Injury.
Topics: Acute Disease; Acute Kidney Injury; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Electronic Health Records; Female; Humans; Infant; Intensive Care Units, Pediatric; Kidney; Male; Models, Statistical; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Reply to Kollef et al.
Topics: Acute Kidney Injury; beta-Lactams; Critical Illness; Humans; Incidence; Vancomycin | 2020 |
Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement.
Topics: Acute Kidney Injury; Analysis of Variance; Area Under Curve; Child; Drug Monitoring; Hospitals, Pediatric; Humans; Infusions, Intravenous; Pharmacy Service, Hospital; Retrospective Studies; Utah; Vancomycin | 2020 |
Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Time Factors; Vancomycin | 2019 |
Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Drug Therapy, Combination; Female; Humans; Kentucky; Male; Middle Aged; Obesity; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2019 |
Vancomycin clearance in high-volume venovenous hemofiltration.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Female; Hemofiltration; Humans; Male; Middle Aged; Vancomycin | 2013 |
Acute kidney injury during vancomycin therapy in critically ill children.
Topics: Acute Kidney Injury; Adolescent; Analysis of Variance; Anti-Bacterial Agents; Blood Urea Nitrogen; Child; Child, Preschool; Cohort Studies; Critical Illness; Female; Glomerular Filtration Rate; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Retrospective Studies; Risk Factors; Time Factors; Vancomycin | 2013 |
Development of acute kidney injury during continuous infusion of vancomycin in septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Prevalence; Sepsis; Vancomycin | 2013 |
Vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Kidney; Vancomycin | 2013 |
Reply to "Vancomycin-induced nephrotoxicity".
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Kidney; Vancomycin | 2013 |
Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Middle Aged; Pharmacovigilance; Prospective Studies; Risk Factors; Time Factors; Vancomycin; Young Adult | 2013 |
Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Hospital Mortality; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Predictive Value of Tests; Retrospective Studies; Risk Factors; Staphylococcal Infections; Trauma Centers; Vancomycin; Wounds and Injuries | 2013 |
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Diabetes Complications; Drug Therapy, Combination; Humans; Incidence; Middle Aged; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Risk factors for acute kidney injury in adult patients receiving vancomycin.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Colistin; Female; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Piperacillin; Renal Replacement Therapy; Thienamycins; Vancomycin | 2014 |
Renal outcome after vancomycin treatment and renal replacement therapy in patients with severe sepsis and septic shock: a retrospective study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; APACHE; Female; Glomerular Filtration Rate; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Middle Aged; Renal Replacement Therapy; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Vancomycin | 2014 |
Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Standard operating procedures for antibiotic therapy and the occurrence of acute kidney injury: a prospective, clinical, non-interventional, observational study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Administration Schedule; Female; Gentamicins; Guideline Adherence; Humans; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Respiration, Artificial; Time Factors; Tobramycin; Vancomycin | 2014 |
High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Creatinine; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Organ Dysfunction Scores; Prevalence; Regression Analysis; Retrospective Studies; Vancomycin | 2014 |
Factors associated with acute kidney injury in children receiving vancomycin.
Topics: Academic Medical Centers; Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Incidence; Infant; Male; Odds Ratio; Retrospective Studies; Risk Factors; Tertiary Care Centers; Vancomycin | 2014 |
Efficacy of high permeability haemodialysis in acute renal failure due to vancomycin.
Topics: Acute Kidney Injury; Aged, 80 and over; Humans; Male; Permeability; Remission Induction; Renal Dialysis; Vancomycin | 2014 |
Risk factors for vancomycin nephrotoxicity: still a matter of debate*.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2014 |
Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefazolin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Severity of Illness Index; Vancomycin | 2015 |
Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cohort Studies; Comorbidity; Critical Illness; Female; Humans; Hypertension; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; ROC Curve; Sepsis; Vancomycin; Young Adult | 2015 |
CORR Insights(®): Addition of Vancomycin to Cefazolin Prophylaxis Is Associated with Acute Kidney Injury After Primary Joint Arthroplasty.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefazolin; Female; Humans; Male; Vancomycin | 2015 |
Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
The authors reply.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
Editor's Spotlight/Take 5: Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Cefazolin; Drug Therapy, Combination; Humans; Vancomycin | 2015 |
Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Asian People; China; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 2015 |
Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria.
Topics: Acute Kidney Injury; Adult; Amphotericin B; Creatinine; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Intensive Care Units; Kidney; Kidney Function Tests; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Vancomycin; Young Adult | 2015 |
Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Diarrhea; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Readmission; Retrospective Studies; Skin Diseases, Bacterial; Vancomycin | 2015 |
Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.
Topics: Acute Kidney Injury; Adolescent; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Inpatients; Male; Time Factors; Vancomycin | 2015 |
Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2016 |
Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Creatinine; Female; Gentamicins; Humans; Incidence; Length of Stay; Male; Middle Aged; Perioperative Period; Prospective Studies; Reoperation; Risk Factors; Surgical Wound Infection; Tobramycin; Vancomycin | 2015 |
The Area Under the Concentration-Time Curve Is a Better Estimate for Vancomycin Exposure Than Trough Levels.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Vancomycin | 2015 |
Factors associated with vancomycin nephrotoxicity in the critically ill.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; APACHE; Critical Illness; Female; Humans; Logistic Models; Male; Middle Aged; Vancomycin | 2015 |
Vancomycin-Associated Nephrotoxicity: The Obesity Factor.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Incidence; Male; Middle Aged; Obesity; Retrospective Studies; Vancomycin | 2015 |
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Agents; Case-Control Studies; Creatinine; Female; Gentamicins; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Recovery of Function; Renal Insufficiency; Retrospective Studies; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin | 2015 |
A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Cohort Studies; Creatinine; Drug Therapy, Combination; Ductus Arteriosus, Patent; Female; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Propensity Score; Retrospective Studies; Risk Factors; Severity of Illness Index; United States; Vancomycin | 2016 |
Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Antifungal Agents; Antihypertensive Agents; Ceftazidime; Cimetidine; Creatinine; Cross-Sectional Studies; Digoxin; Diuretics; Drug Dosage Calculations; Drug Prescriptions; Enalapril; Ethiopia; Female; Fluconazole; Gout Suppressants; Hospitalization; Humans; Male; Medication Errors; Middle Aged; Pharmaceutical Preparations; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Spironolactone; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2015 |
Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam; Vancomycin | 2015 |
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Propensity Score; Recurrence; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2016 |
Acute kidney injury in ELBW infants (< 750 grams) and its associated risk factors.
Topics: Abruptio Placentae; Acute Kidney Injury; Adult; Amphotericin B; Anti-Bacterial Agents; Case-Control Studies; Cefotaxime; Clindamycin; Creatinine; Diuretics; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Female; Furosemide; Humans; Hydrochlorothiazide; Infant, Extremely Low Birth Weight; Infant, Newborn; Infections; Intracranial Hemorrhages; Ohio; Parenteral Nutrition, Total; Pregnancy; Prevalence; Respiration, Artificial; Retrospective Studies; Risk Factors; Steroids; Survival Rate; Time Factors; Uterine Hemorrhage; Vancomycin; Young Adult | 2015 |
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Drug Therapy, Combination; Female; Hospital Departments; Humans; Interrupted Time Series Analysis; Male; Middle Aged; Patient Safety; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Veterans | 2016 |
Continuous Infusion Vancomycin Through the Addition of Vancomycin to the Continuous Renal Replacement Therapy Solution in the PICU: A Case Series.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Renal Replacement Therapy; Retrospective Studies; Vancomycin | 2016 |
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin | 2017 |
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Reducing acute kidney injury due to vancomycin in trauma patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Biomarkers; Creatinine; Dose-Response Relationship, Drug; Female; Glasgow Coma Scale; Hospital Mortality; Humans; Injury Severity Score; Male; Middle Aged; Risk Factors; Vancomycin; Wounds and Injuries | 2016 |
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Topics: Acute Kidney Injury; Animals; Biomarkers; Kidney; Male; Rats, Sprague-Dawley; Vancomycin | 2016 |
Enigma: infection or allergy? Vancomycin-induced DRESS syndrome with dialysis-dependent renal failure and cardiac arrest.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Glucocorticoids; Heart Arrest; Humans; Male; Prednisolone; Renal Dialysis; Vancomycin | 2016 |
Impact of a Pharmacist-Initiated Vancomycin Monitoring Program.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Drug Monitoring; Female; Humans; Incidence; Kidney Function Tests; Male; Middle Aged; Pharmaceutical Services; Pharmacists; Program Development; Retrospective Studies; Skilled Nursing Facilities; Vancomycin | 2016 |
Vancomycin Trough Levels: Cause or Result of Acute Kidney Injury?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Humans; Retrospective Studies; Vancomycin | 2016 |
Vancomycin Trough and Acute Kidney Injury: A Large Retrospective, Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 2016 |
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Vancomycin and the Risk of AKI: Now Clearer than Mississippi Mud.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Humans; Risk; Vancomycin | 2016 |
p53 activates miR-192-5p to mediate vancomycin induced AKI.
Topics: Acute Kidney Injury; Animals; Apoptosis; Benzothiazoles; Blood Urea Nitrogen; Cell Cycle; Cell Line; Epithelial Cells; Genes, p53; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Toluene; Tumor Suppressor Protein p53; Vancomycin | 2016 |
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Topics: Acute Kidney Injury; Adolescent; Case-Control Studies; Child; Child, Preschool; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Furosemide; Gentamicins; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Retrospective Studies; Risk; Severity of Illness Index; Vancomycin | 2017 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cohort Studies; Creatinine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin | 2017 |
Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Young Adult | 2017 |
Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Retrospective Studies; Sepsis; Treatment Outcome; Vancomycin | 2017 |
Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Critical Illness; Female; France; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
Vancomycin-induced DRESS syndrome in a female patient.
Topics: Acute Kidney Injury; Anti-Allergic Agents; Anti-Bacterial Agents; Drug Eruptions; Eosinophilia; Female; Fever; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Mometasone Furoate; Pregnadienediols; Syndrome; Vancomycin | 2008 |
Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aneurysm, Infected; Daptomycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Vancomycin | 2008 |
Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.
Topics: Acute Disease; Acute Kidney Injury; Administration, Oral; Aged; Anti-Bacterial Agents; Biological Availability; Drug Monitoring; Enterocolitis, Pseudomembranous; Hemodiafiltration; Humans; Male; Necrosis; Pancreatitis, Alcoholic; Severity of Illness Index; Vancomycin | 2009 |
Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Staphylococcus aureus; Vancomycin; Young Adult | 2010 |
Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Biomarkers; California; Child; Child, Preschool; Creatinine; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Humans; Incidence; Infant; Infant, Newborn; Logistic Models; Male; Microbial Sensitivity Tests; Multivariate Analysis; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2011 |
New target concentrations for vancomycin in Hong Kong.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Hong Kong; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Plasma; Staphylococcal Infections; Vancomycin | 2011 |
Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Biomarkers; Creatinine; Female; Humans; Incidence; Kidney; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2010 |
Vancomycin nephrotoxicity may be overstated.
Topics: Acute Kidney Injury; Humans; Infant, Newborn; Infusions, Intravenous; Kidney; Male; Vancomycin | 2011 |
Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Creatinine; Female; Humans; Kidney; Male; Middle Aged; Prospective Studies; Vancomycin | 2011 |
Acute renal failure after topical fortified gentamicin and vancomycin eyedrops.
Topics: Acute Kidney Injury; Administration, Topical; Aged; Anti-Bacterial Agents; Endophthalmitis; Female; Gentamicins; Humans; Ophthalmic Solutions; Vancomycin | 2011 |
Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Female; Hospital Costs; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Teicoplanin; Vancomycin | 2011 |
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aortic Valve; Aza Compounds; Biopsy; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Endocarditis, Bacterial; Eosinophilia; Fluoroquinolones; Glucocorticoids; Humans; Kidney; Legionnaires' Disease; Male; Meropenem; Moxifloxacin; Nephritis, Interstitial; Quinolines; Sepsis; Skin; Thienamycins; Vancomycin | 2012 |
Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.
Topics: Acute Kidney Injury; Cohort Studies; Female; Hospitals, Veterans; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Veterans | 2012 |
The relationship between serum neutrophil gelatinase-associated lipocalin and renal function in patients with vancomycin treatment.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Lipocalin-2; Lipocalins; Male; Middle Aged; Proto-Oncogene Proteins; Vancomycin | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin | 2012 |
[Listeria monocytogenes endocarditis: two case reports with poor outcome].
Topics: Acute Kidney Injury; Aged; Ampicillin; Anti-Bacterial Agents; Endocarditis, Bacterial; Fatal Outcome; Female; Humans; Listeriosis; Male; Middle Aged; Multiple Organ Failure; Myocardial Infarction; Vancomycin | 2012 |
[Antimicrobial dosing in critically ill patients requiring renal replacement therapy - maximize efficacy and minimize toxicity!].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Drug Monitoring; Female; Hemofiltration; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2014 |
Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cord Blood Stem Cell Transplantation; Drug Monitoring; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Transplantation Conditioning; Vancomycin; Young Adult | 2013 |
Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Critical Illness; Cross-Over Studies; Female; Hemofiltration; Humans; Male; Middle Aged; Multiple Organ Failure; Prospective Studies; Shock, Septic; Vancomycin | 2002 |
[Efficacy and nephrotoxicity of vancomycin in the treatment of Gram positive infections].
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Male; Middle Aged; Retrospective Studies; Vancomycin | 2003 |
Antibiotic resistant Streptococcus pneumoniae and hemolytic uremic syndrome.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Peritoneal Dialysis; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2005 |
Large-pore haemodialysis membranes: an efficient tool for rapid removal of vancomycin after accidental overdose.
Topics: Acute Kidney Injury; Child; Female; Humans; Membranes, Artificial; Renal Dialysis; Vancomycin | 2005 |
Exfoliative dermatitis, fever and acute renal failure in a 60% burns patient.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Burns, Chemical; Dermatitis, Exfoliative; Drug Eruptions; Fever; Humans; Male; Retrospective Studies; Vancomycin; Wound Infection | 2005 |
Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cyclosporine; Drug Hypersensitivity; Endocarditis, Bacterial; Eosinophilia; Female; Humans; Immunosuppressive Agents; Middle Aged; Syndrome; Vancomycin | 2005 |
Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis.
Topics: Acute Kidney Injury; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Intensive Care Units; Kidney Function Tests; Male; Meropenem; Renal Dialysis; Risk Assessment; Thienamycins; Treatment Outcome; Vancomycin | 2006 |
Clearance of linezolid via continuous venovenous hemodiafiltration.
Topics: Acetamides; Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Hemofiltration; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Time Factors; Urinary Tract Infections; Vancomycin | 2006 |
Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Bone Cements; Female; Humans; Male; Postoperative Complications; Tobramycin; Vancomycin | 2006 |
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
Topics: Acute Kidney Injury; Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Creatinine; Humans; Infusions, Intravenous; Kidney Function Tests; Logistic Models; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2008 |
Antibiotic persistence during renal failure and dialysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Glomerular Filtration Rate; Humans; Kanamycin; Neomycin; Renal Dialysis; Streptomycin; Vancomycin | 1967 |
Comparison of vancomycin disposition in rats with normal and abnormal renal functions.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Male; Rats; Rats, Inbred Strains; Tissue Distribution; Uranyl Nitrate; Vancomycin | 1981 |
Acute renal failure due to vancomycin alone.
Topics: Acute Kidney Injury; Aged; Dose-Response Relationship, Drug; Humans; Male; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
[Intermittent mini-dose vancomycin intravenous administration and closed continuous irrigation technique applied to mediastinitis caused by MRSA following mitral valve replacement].
Topics: Acute Kidney Injury; Female; Heart Valve Prosthesis; Humans; Infusions, Intravenous; Mediastinitis; Mediastinum; Methicillin Resistance; Middle Aged; Mitral Valve; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Irrigation; Vancomycin | 1995 |
Decreased urine output after surgery in a neonate.
Topics: Acute Kidney Injury; Adult; Drug Therapy, Combination; Female; Gentamicins; Humans; Hydrocephalus; Infant, Newborn; Male; Meningomyelocele; Oliguria; Postoperative Complications; Vancomycin | 1994 |
Systemic absorption after local intracolonic vancomycin in pseudomembranous colitis.
Topics: Acute Kidney Injury; Enterocolitis, Pseudomembranous; Hemofiltration; Humans; Intestinal Absorption; Vancomycin | 1993 |
Acute renal failure and gastrointestinal bleed associated with postoperative toradol and vancomycin.
Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Gastrointestinal Hemorrhage; Humans; Ketorolac Tromethamine; Male; Postoperative Period; Tolmetin; Tromethamine; Vancomycin | 1993 |
Vancomycin dosing in haemodialysis patients and Bayesian estimate of individual pharmacokinetic parameters.
Topics: Acute Kidney Injury; Aged; Bayes Theorem; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Vancomycin | 1994 |
Effect of oral activated charcoal on vancomycin clearance in rabbits with acute renal failure.
Topics: Acute Kidney Injury; Animals; Biological Assay; Charcoal; Creatinine; Male; Rabbits; Staphylococcus aureus; Uranyl Nitrate; Vancomycin | 1993 |
Pharmacokinetics of vancomycin during continuous hemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; France; Half-Life; Hemodiafiltration; Hemodialysis Solutions; Humans; Male; Middle Aged; Prospective Studies; Time Factors; Vancomycin | 1993 |
Vancomycin removal by plasmapheresis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Combined Modality Therapy; Female; Humans; Plasmapheresis; Pregnancy; Protein Binding; Vancomycin | 1996 |
[Acute interstitial nephropathy induced by vancomycin].
Topics: Acute Disease; Acute Kidney Injury; Aged; Endocarditis, Bacterial; Enterococcus; Female; Humans; Nephritis, Interstitial; Vancomycin | 1996 |
Renal excretion of vancomycin in rats with acute renal failure.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Cisplatin; Kidney Function Tests; Male; Rats; Rats, Wistar; Uranyl Nitrate; Vancomycin | 1997 |
Vancomycin removal by plasmapheresis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; Drug Monitoring; Humans; Plasmapheresis; Vancomycin | 1997 |
Vancomycin assay performance in patients with acute renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Enzyme Multiplied Immunoassay Technique; Female; Fluorescence Polarization Immunoassay; Hemofiltration; Humans; Male; Middle Aged; Reproducibility of Results; Vancomycin | 1999 |
Rapid removal of vancomycin by continuous veno-venous hemofiltration.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Female; Hemofiltration; Humans; Staphylococcal Infections; Vancomycin; Ventriculoperitoneal Shunt | 2000 |
Streptococcus pneumoniae-induced acute renal failure in a neonate.
Topics: Acute Kidney Injury; Ampicillin; Anticoagulants; Blood Transfusion; Ceftazidime; Drug Therapy, Combination; Enteral Nutrition; Enterocolitis, Necrotizing; Exchange Transfusion, Whole Blood; Humans; Infant, Newborn; Male; Pneumococcal Infections; Respiration, Artificial; Streptococcus pneumoniae; Vancomycin | 2000 |
[To avoid complications, treatment of meningitis should follow the guidelines and be reevaluated at 48 hours].
Topics: Acute Kidney Injury; Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Female; Guidelines as Topic; Humans; Meningitis, Pneumococcal; Penicillins; Rifampin; Time Factors; Vancomycin | 2000 |
Successful medical treatment of acute bilateral emphysematous pyelonephritis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Combined Modality Therapy; Diabetes Mellitus, Type 2; Emphysema; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Pyelonephritis; Sepsis; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Disease Outbreaks; Female; Humans; Male; Middle Aged; Vancomycin | 2001 |
Large atrial septal aneurysm and delayed improvement of renal failure due to nephrotoxic drugs (and hemodialysis) in a diabetic patient.
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Coronary Aneurysm; Diabetes Complications; Diabetes Mellitus; Endocarditis; Female; Heart Septal Defects, Atrial; Humans; Middle Aged; Time Factors; Ultrasonography; Vancomycin | 2002 |
Antibiotic managment in renal failure.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Humans; Kidney Failure, Chronic; Penicillins; Polymyxins; Tetracyclines; Urologic Diseases; Vancomycin | 1976 |
Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Ciprofloxacin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Vancomycin | 1992 |
Vancomycin levels and acute renal failure.
Topics: Acute Kidney Injury; Humans; Vancomycin | 1992 |
Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance.
Topics: Acute Kidney Injury; Adult; Aged; Female; Hemofiltration; Humans; Male; Middle Aged; Prospective Studies; Vancomycin | 1991 |
Elimination of vancomycin in patients on continuous arteriovenous hemodialysis.
Topics: Acute Kidney Injury; Female; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Vancomycin | 1991 |
Clearance of vancomycin during continuous arteriovenous hemodiafiltration.
Topics: Acute Kidney Injury; Hemofiltration; Humans; Vancomycin | 1990 |
Elimination of vancomycin during hemofiltration.
Topics: Acute Kidney Injury; Hemofiltration; Humans; Vancomycin | 1989 |
High-level vancomycin-resistant enterococci causing hospital infections.
Topics: Acute Kidney Injury; Conjugation, Genetic; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Humans; Kidney Diseases; R Factors; Streptococcal Infections; Streptococcus; Vancomycin | 1989 |
Use of aminoglycosides during cyclosporine A immunosuppression after liver transplantation in children.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Child; Child, Preschool; Cyclosporins; Drug Therapy, Combination; Female; Humans; Infant; Liver Transplantation; Male; Postoperative Complications; Risk Factors; Vancomycin | 1989 |
Post-traumatic toxic shock syndrome.
Topics: Acute Kidney Injury; Adult; Fluid Therapy; Humans; Male; Postoperative Complications; Renal Dialysis; Shock, Septic; Staphylococcus aureus; Vancomycin; Wound Infection; Wounds, Stab | 1988 |
[Reputedly nephrotoxic antibiotic therapy during severe infections].
Topics: Acute Kidney Injury; Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Colistin; Deafness; Endocarditis, Bacterial; Female; Humans; Kanamycin; Kidney; Kidney Function Tests; Male; Middle Aged; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections; Urea; Vancomycin | 1972 |
Cephaloridine (Loridine).
Topics: Acute Kidney Injury; Cephaloridine; Cephalothin; Humans; Kanamycin; Penicillin Resistance; Vancomycin | 1968 |
Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis.
Topics: Acute Kidney Injury; Adult; Humans; Kidney Diseases; Kidneys, Artificial; Staphylococcal Infections; Vancomycin | 1966 |